This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Fragment-Based Drug Discovery
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | == Paclitaxel in Apoptosis == | + | <s></s>== Paclitaxel in Apoptosis == |
<StructureSection load='1ysi' size='350' side='right' caption='Structure of HMG-CoA reductase (PDB entry [[1ysi]])' scene=''> | <StructureSection load='1ysi' size='350' side='right' caption='Structure of HMG-CoA reductase (PDB entry [[1ysi]])' scene=''> | ||
This represents the inhibition of the anti-apoptotic protein, Bcl-xl, by the anti-cancer drug, paclitaxel. | This represents the inhibition of the anti-apoptotic protein, Bcl-xl, by the anti-cancer drug, paclitaxel. | ||
| + | |||
| + | Shown here is the interaction between paclitaxel and the protein via <scene name='Sandbox_reserved_394/Hydrogen_bonds/3'>hydrogen bonding</scene>. | ||
| + | |||
| + | |||
| + | Shown here is the <scene name='Sandbox_reserved_394/Hydrophobic_bonding/3'>hydrophobic bonding</scene> formed between the protein (grey) and a hydrophobic portion of paclitaxel (blue). | ||
</StructureSection> | </StructureSection> | ||
Revision as of 17:45, 19 September 2012
== Paclitaxel in Apoptosis ==
| |||||||||||
